Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Morris

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
Neuroreport|February 16, 2000
The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodiesW Xu, L Liu, P Emson, et al.
Growth Factors (Chur, Switzerland)|January 1, 1994
Isolation and characterization of the human DTK receptor tyrosine kinaseK E Crosier, L R Hall, P M Lewis, et al.
European Journal of Haematology|July 22, 2006
Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progressionChristine Matthews, Mark A Catherwood, T C M Morris, et al.
Biology of the Cell|January 1, 1992
The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS)J M Candy, A E Oakley, S A Mountfort, et al.
Neurology|May 23, 2007
Individual dopaminergic neurons show raised iron levels in Parkinson diseaseA E Oakley, J F Collingwood, J Dobson, et al.
Neuropathology and Applied Neurobiology|November 14, 2018
Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's diseaseN N Vaikath, D Erskine, C M Morris, et al.
Cancer Genetics and Cytogenetics|January 1, 1983
Nonrandom cytogenetic changes in New Zealand patients with acute myeloid leukemiaP H Fitzgerald, C M Morris, G J Fraser, et al.
Lancet (London, England)|August 13, 1994
Protective effect of apoE epsilon 2 in Alzheimer's diseaseR Benjamin, A Leake, F K McArthur, et al.
British Journal of Haematology|September 9, 2004
A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myelomaG Cook, R E Clark, T C M Morris, et al.
The Journal of Hospital Infection|February 5, 2002
Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospitalJ Jugo, R Kennedy, M J Crowe, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Neuroreport|February 16, 2000
The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodiesW Xu, L Liu, P Emson, et al.
Growth Factors (Chur, Switzerland)|January 1, 1994
Isolation and characterization of the human DTK receptor tyrosine kinaseK E Crosier, L R Hall, P M Lewis, et al.
European Journal of Haematology|July 22, 2006
Serum TK levels in CLL identify Binet stage A patients within biologically defined prognostic subgroups most likely to undergo disease progressionChristine Matthews, Mark A Catherwood, T C M Morris, et al.
Biology of the Cell|January 1, 1992
The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS)J M Candy, A E Oakley, S A Mountfort, et al.
Neurology|May 23, 2007
Individual dopaminergic neurons show raised iron levels in Parkinson diseaseA E Oakley, J F Collingwood, J Dobson, et al.
Neuropathology and Applied Neurobiology|November 14, 2018
Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's diseaseN N Vaikath, D Erskine, C M Morris, et al.
Cancer Genetics and Cytogenetics|January 1, 1983
Nonrandom cytogenetic changes in New Zealand patients with acute myeloid leukemiaP H Fitzgerald, C M Morris, G J Fraser, et al.
Lancet (London, England)|August 13, 1994
Protective effect of apoE epsilon 2 in Alzheimer's diseaseR Benjamin, A Leake, F K McArthur, et al.
British Journal of Haematology|September 9, 2004
A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myelomaG Cook, R E Clark, T C M Morris, et al.
The Journal of Hospital Infection|February 5, 2002
Trends in bacteraemia on the haematology and oncology units of a UK tertiary referral hospitalJ Jugo, R Kennedy, M J Crowe, et al.
Pageof 21